Trends in Molecular Testing of Lung Cancer in Mainland People’s Republic of China Over the Decade 2010 to 2019

Trends in Molecular Testing of Lung Cancer in Mainland People’s Republic of China Over the Decade 2010 to 2019

Introduction: Lung cancer is the leading cause of cancer-related morbidity and mortality in the People’s Republic of China. Targeted therapies for patients with lung cancer, which depend on accurate identification of actionable genomic alteration, have improved survival compared with previously avai...

Full description

Bibliographic Details
Main Authors: Wenbin Li, PhD, Yunfeng Lyu, PhD, Shaoming Wang, PhD, Xiaoyan Zhou, MD, PhD, Jie Ma, MD, Chao Xu, MS, Li Fang, MS, Jianming Ying, MD, PhD, Lei Guo, Tian Qiu, Weihua Li, Yan Li, Nanying Che, Xuefeng Bai, Yanfeng Xi, Yanping Hu, Liping Liu, Xuemei Li, Shujun Zhang, Hongxue Meng, Xiumei Duan, Yan Wu, Lian He, Nan Liu, Jie He, Hong Li, Zhihui Yang, Jie Lin, Yi Shi, Xiaoyan Li, Meihong Yao, Qianming Bai, Ling Xie, Xinghua Zhu, Aiyan Xing, Zebing Liu, Lei Dong, Wentao Huang, Jie Huang, Guohua Yu, Xiaotong Hu, Dan Su, Bing Wei, Fang Guo, Ziguang Xu, Guozhong Jiang, Qian Cui, Jia Li, Xianhua Xu, Juan Jiao, Xinhui Fu, Nengtai Ouyang, Xiaojuan Li, Xiaoying Zhu, Yanjie Liu, Qiushi Wang, Qiong Liao, Zhuo Zuo, Tao Luo, Chenggang Yang, Xiaoming Wang, Xi Liu, Wenli Cui
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:JTO Clinical and Research Reports
Subjects:
Lung cancer
Molecular testing
Trends
NMPA
China
Online Access:http://www.sciencedirect.com/science/article/pii/S2666364321000229

Internet

http://www.sciencedirect.com/science/article/pii/S2666364321000229

Similar Items